Panelist discusses how the future treatment landscape for EGFR-mutant advanced non–small cell lung cancer is evolving to address current unmet needs and offers clinical pearls to community oncologists ...

A new study has found a surprising link between high levels of methylmalonic acid and the weakening of CD8+ T cells, shedding ... which aging may promote lung cancer progression.

Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages ...

While traditional banking institutions have long been the go-to source for business loans, non-traditional lending companies are emerging as game-changers for small businesses in Nigeria. Focus on ...

1Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 2Key Clinical Laboratory of Henan Province, Zhengzhou, China. *Corresponding Author: Cai ...

Fortunately, we have screening tests for all four of these cancers: mammograms for breast cancer; the PSA blood test for prostate cancer; CT scans for lung cancer ... or kill. A small growth ...

Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing. Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy ...

The company’s self-developed original new drug, Chiauranib, combined with PD - (L) 1 monoclonal antibody and standard chemotherapy for the first-line treatment of extensive stage small cell lung ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary b ...

"It is a small and efficient pilot in which we aim to identify participants in the north Dublin and the northeast area, who are at high risk for lung cancer based ... end with a CT scan," she ...